High Fidelity Restriction Endonucleases
US-2024352437-A1 · Oct 24, 2024 · US
US9315789B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9315789-B2 |
| Application number | US-201414146389-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jan 2, 2014 |
| Priority date | Apr 28, 2005 |
| Publication date | Apr 19, 2016 |
| Grant date | Apr 19, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Antibody/signal-generating moiety conjugates are disclosed that include an antibody covalently linked to a signal-generating moiety through a heterobifunctional polyalkyleneglycol linker. The disclosed conjugates show exceptional signal-generation in immunohistochemical and in situ hybridization assays on tissue sections and cytology samples. In one embodiment, enzyme-metallographic detection of nucleic acid sequences with hapten-labeled probes can be accomplished using the disclosed conjugates as a primary antibody without amplification.
Opening claim text (preview).
We claim: 1. An antibody-PEG linker-enzyme signal-generating moiety conjugate, comprising: an antibody; a plurality of enzyme signal-generating moieties; and a plurality of monodisperse, heterobifunctional PEG linkers, wherein each enzyme signal-generating moiety is linked to the antibody through at least one of the plurality of monodisperse, heterobifunctional PEG linker to provide the antibody-PEG linker-enzyme signal-generating moiety conjugate having the formula wherein Ab is the antibody, SM is the enzyme signal-generating moiety, n=4 to 12 and s=3 to 10. 2. The conjugate of claim 1 , wherein SM is an oxido-reductase enzyme. 3. The conjugate of claim 1 , wherein each SM independently is horseradish peroxidase, alkaline phosphatase, acid phosphatase, glucose oxidase, β-galactosidase, β-glucuronidase or β-lactamase. 4. The conjugate of claim 1 , wherein each SM independently is horseradish peroxidase or alkaline phosphatase. 5. The conjugate of claim 1 , wherein SM is alkaline phosphatase. 6. The conjugate of claim 1 , wherein SM is horseradish peroxidase. 7. The conjugate of claim 1 , wherein the antibody comprises an anti-antibody antibody. 8. The conjugate of claim 7 , wherein the anti-antibody antibody is an anti-IgG antibody. 9. The conjugate of claim 1 , wherein the antibody comprises an anti-hapten antibody. 10. The conjugate of claim 1 , wherein s=3 to 6. 11. The conjugate of claim 10 , wherein s=3 to 4. 12. The conjugate of claim 11 , wherein SM is horseradish peroxidase or alkaline phosphatase.
with enzyme label {or co-enzymes, co-factors, enzyme inhibitors or enzyme substrates} · CPC title
against material not provided for elsewhere {, e.g. haptens, metals, DNA, RNA, amino acids} · CPC title
acting on ester bonds (3.1) · CPC title
acting on hydrogen peroxide as acceptor (1.11) · CPC title
against immunoglobulins · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.